CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 852886-853064
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T38261","span":{"begin":0,"end":178},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Currently licensed therapies for MS include forms of interferon beta as well as more specifically targeted agents directed at adhesion molecules and the antigen receptor complex."}
Epistemic_Statements
{"project":"Epistemic_Statements","denotations":[{"id":"T1884","span":{"begin":0,"end":178},"obj":"Epistemic_statement"}],"text":"Currently licensed therapies for MS include forms of interferon beta as well as more specifically targeted agents directed at adhesion molecules and the antigen receptor complex."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T99","span":{"begin":0,"end":178},"obj":"Sentence"}],"text":"Currently licensed therapies for MS include forms of interferon beta as well as more specifically targeted agents directed at adhesion molecules and the antigen receptor complex."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T3606","span":{"begin":33,"end":35},"obj":"Body_part"}],"attributes":[{"id":"A3606","pred":"uberon_id","subj":"T3606","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"Currently licensed therapies for MS include forms of interferon beta as well as more specifically targeted agents directed at adhesion molecules and the antigen receptor complex."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5355","span":{"begin":33,"end":35},"obj":"Disease"},{"id":"T87437","span":{"begin":33,"end":35},"obj":"Disease"}],"attributes":[{"id":"A5355","pred":"mondo_id","subj":"T5355","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A52300","pred":"mondo_id","subj":"T87437","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"Currently licensed therapies for MS include forms of interferon beta as well as more specifically targeted agents directed at adhesion molecules and the antigen receptor complex."}